Study of Nivolumab for Advanced Cancers in India

Conditions:   Non-Small Cell Lung Cancer (NSCLC);   Non-Small-Cell Lung Carcinoma;   Nonsmall Cell Lung Cancer;   Kidney Cancer;   Kidney Neoplasms;   Renal Cancer;   Renal Neoplasms Intervention:   Drug: Nivolumab Sponsor:   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials